Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > USA. S. Tucatinib+Capecitabine>+

---

USA. S. Tucatinib+Capecitabine>+'s subsections
(*) AU Approval Date: 2020. 08.12.
(*) USA Approval Date: 2020. 04.17.
+TrastuzuMAb
>UnResectable Advanced
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2020. 04.14.
TradeMark
TradeMark Web-Site

USA. S. Tucatinib+Capecitabine>+'s products
This section has no products